Axcelis Technologies, Inc.
NASDAQ:ACLSSemiconductors
+$11.85 today
- Market cap
- $3.03B
- Beta
- 1.92
- P/E (TTM)
- 57.0
- EPS (TTM)
- $3.28
Volume 0.24M
Average 0.70M
ACLS EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Axcelis Technologies, Inc.NASDAQ: ACLS
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $42.46M rose 23.1% year over year, ahead of the -24.0% change in trailing-twelve-month EBITDA. Sequentially, it rose 36.7% from the prior quarter. Over 3 fiscal years it compounded at -10.1% a year.
Context
- EBITDA amounted to 19.2% of revenue in FY2025, down 5.5 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $185.19M (+14.9%) for the fiscal year ending Dec 2026, a step up from the -35.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $42.46M+36.7% QoQ
- Last fiscal yearDec 2025
- $161.23M-35.9% YoY
- LTMSep 2026
- $135.68M-24.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +23.1% | +30.7% | +7.5 pp |
| 1 year | -35.9% | +14.9% | +50.8 pp |
| 3-year CAGR | -10.1% | +25.6% | +35.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 161.23M USD
- Year-over-year change
- -35.9%
- 4-year CAGR
- +4.3%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 161.23M | -35.9% |
| FY2024 | 2024-12-31 | 251.55M | -15.3% |
| FY2023 | 2023-12-31 | 297.02M | +33.7% |
| FY2022 | 2022-12-31 | 222.07M | +63.2% |
| FY2021 | 2021-12-31 | 136.08M | — |
EBITDA vs competitors
How ACLS compares with its peers on the latest reported figures
- ACLS's LTM Sep 2026 EBITDA of $135.68M is the 9th highest of the 11 companies compared; the peer median is $259.05M.
- Its year-over-year change of -24.0% is the 9th highest of 11, against a peer median of +14.3%.
- EBITDA amounts to 15.2% of revenue for ACLS, versus a peer median of 21.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $10.18B | +45.2% | +15.6% | 38.9% | |
| LTM Jun 2026 | $6.05B | +13.4% | +10.4% | 44.6% | |
| LTM Jun 2026 | $880.1M | -3.6% | +4.5% | 26.5% | |
| LTM May 2026 | $320.12M | +4.6% | -2.3% | 37.2% | |
| LTM Sep 2026 | $298.39M | +21.3% | -10.0% | 22.7% | |
| LTM Sep 2026 | $219.7M | +15.3% | +28.7% | 19.3% | |
| LTM Sep 2026 | $182.8M | +2749.3% | — | 7.5% | |
| LTM Jul 2026 | $160.63M | +275.6% | -57.4% | 16.9% | |
| LTM Sep 2026 | $135.68M | -24.0% | -10.1% | 15.2% | |
| LTM Sep 2026 | $43.58M | -41.6% | -8.0% | 6.0% | |
| LTM May 2026 | -$8.21M | -808.7% | — | 16.1% | |
| Peer median (excluding ACLS) | $259.05M | +14.3% | +1.1% | 21.0% | |
Competitors are the stored peer set for ACLS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 662.43M | 920M | 1.13B | 1.02B | 839.05M |
| Cost of Revenue | 375.98M | 518.21M | 639.3M | 563.21M | 462.2M |
| Gross Profit | 286.45M | 401.79M | 491.3M | 454.65M | 376.85M |
| Gross Margin | 43.2% | 43.7% | 43.5% | 44.7% | 44.9% |
| Research & Development | 65.43M | 78.36M | 96.91M | 105.5M | 108.96M |
| Selling, General & Admin | 93.69M | 111.07M | 128.6M | 138.36M | 148.58M |
| Operating Expenses | 159.12M | 189.43M | 225.51M | 243.86M | 257.53M |
| Depreciation & Amortization | 10.82M | 11.61M | 13.07M | 15.81M | 17.61M |
| EBITDA | 136.08M | 222.07M | 297.02M | 251.55M | 161.23M |
| EBITDA Margin | 20.5% | 24.1% | 26.3% | 24.7% | 19.2% |
| Operating Income | 127.33M | 212.36M | 265.8M | 210.79M | 119.32M |
| Operating Margin | 19.2% | 23.1% | 23.5% | 20.7% | 14.2% |
| Interest Income | 209K | 4.55M | 18.2M | 24.4M | 21.48M |
| Interest Expense | 4.84M | 5.58M | 5.35M | 5.46M | 5.36M |
| Other Income / Expenses | (6.9M) | (7.48M) | 12.8M | 19.48M | 18.93M |
| Income Before Tax | 120.43M | 204.89M | 278.6M | 230.27M | 138.25M |
| Pre-Tax Margin | 18.2% | 22.3% | 24.6% | 22.6% | 16.5% |
| Income Tax Expense | 21.78M | 21.81M | 32.34M | 29.28M | 18.01M |
| Net Income | 98.65M | 183.08M | 246.26M | 200.99M | 120.24M |
| Net Margin | 14.9% | 19.9% | 21.8% | 19.7% | 14.3% |
| EPS (Basic) | 2.94 | 5.54 | 7.52 | 6.17 | 3.81 |
| EPS (Diluted) | 2.88 | 5.46 | 7.43 | 6.15 | 3.80 |
| Weighted Avg Shares | 33.56M | 33.04M | 32.76M | 32.55M | 31.57M |
| Weighted Avg Shares (Diluted) | 34.27M | 33.54M | 33.17M | 32.7M | 31.67M |
Axcelis Technologies, Inc.
NASDAQ:ACLS
Intrinsic Alpha fair value
Locked
Current Price
$97.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.